# Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

> **NCT02864810** · PHASE1 · COMPLETED · sponsor: **Asan Foundation** · enrollment: 32 (actual)

## Conditions studied

- Thromboembolism

## Interventions

- **DRUG:** [18F]GP1

## Key facts

- **NCT ID:** NCT02864810
- **Lead sponsor:** Asan Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-04
- **Primary completion:** 2017-09-09
- **Final completion:** 2017-09-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864810, "Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02864810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*